Recent Events & Catalysts
Madrigal Pharmaceuticals, Inc. (MDGL) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
SeekingAlpha · today
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Yahoo · 5d ago
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
Yahoo · 5d ago
Madrigal Pharmaceuticals: Semaglutide Launch No Issue, Wise Pipeline Approach
SeekingAlpha · 6d ago
Walmart downgraded, Palantir upgraded: Wall Street's top analyst calls
Yahoo · 7d ago
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, CoreWeave, eBay, Exxon Mobil, Intuit, Nebius Group, Palantir Technologies, SK hynix, and More
Yahoo · 7d ago
This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 7d ago
Wolfe Research Upgrades Madrigal Pharmaceuticals to Outperform, Announces $605 Price Target
Benzinga · 7d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-30 · 12d ago · Material
Departure/appointment of directors or officers, Submission of matters to a vote of security holders, Financial statements and exhibits
Filed 2026-06-17 · 55d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.